Risk assessment algorithms, such as that used in the third Adult Treatment Panel (ATP III) of
the National Cholesterol Education Program (NCEP) for treating low-density lipoprotein
cholesterol, can be used to classify patients' risk for cardiovascular and metabolic problems
and to determine the appropriate level of therapeutic intervention. Patients at highest risk
should receive the most intensive therapy. The presence of the metabolic syndrome, a
clustering of atherogenic risk factors including dyslipidemia, elevated blood pressure …